Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
hypertension-treatment-settlement
Press Release
Aug 10, 2017
Consumer Safety Watch: Questions and Answers About the $300 Million Settlement Involving the Drug Olmesartan
Consumer Safety Watch answers the following questions: Is it too late to qualify? Is there a deadline? What are the criteria to be part of the settlement?
Read More
First
Prev
1
Next
Last
